Molecular markers, internal reference genes and application thereof, detection kit and method for constructing detection model
A technology of molecular markers and internal reference genes, which is applied in biochemical equipment and methods, microbiological determination/inspection, DNA/RNA fragments, etc., can solve problems such as expensive, genes and their detection models that have yet to be verified, and achieve reduction Effects of over-treatment and inappropriate treatment, satisfying individualized precise treatment, and perfecting technical methods
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] The collection of embodiment 1 sample, the arrangement of sample data
[0063] Using FFPE samples from newly diagnosed breast cancer patients without treatment, systematically collected complete clinical follow-up data, and through sorting out the sample data, the inventor selected 341 samples that met the following criteria as TLDA (Taqman LowDensity Array, TLDA) chip detection And a series of experimental samples verified by qRT-PCR:
[0064] (1) newly diagnosed patients with untreated early and mid-stage breast cancer;
[0065] (2) Patients with untreated early, mid-stage ER or (and) PR-positive breast cancer;
[0066] (3) LN has or (and) has not been transferred, and the amount of LN transferred;
[0067] (4) Accurate and detailed follow-up information is available.
Embodiment 2
[0068] Example 2 TLDA chip screening molecular markers and internal reference genes
[0069] TLDA chip detection was performed on 26 breast cancer samples with good prognosis and 26 breast cancer samples with poor prognosis that met the above conditions, and relevant results were obtained. The specific steps are:
[0070] (1) RNA extraction from FFPE samples: 4 slices of 20 μm slices or 8 slices of 10 μm slices were taken from each sample, and RNA was extracted according to the instruction of HighPure FFPET RNA Isolation Kit (Roche), and the extracted RNA was quantitatively controlled by NanoDrop-2000 Afterwards, downstream reverse transcription experiments were performed.
[0071] (2) cDNA sample was obtained by reverse transcription reaction of total RNA: take 1 μg total RNA according to VILO TM Master Mix kit (Invitrogen) manual was used for reverse transcription.
[0072] (3) TLDA detection of cDNA samples: the above cDNA products and After the Universal PCR MasterM...
Embodiment 3
[0077] Example 3 Large sample size qRT-PCR verification of molecular markers
[0078] 14 molecular markers and 5 internal reference genes screened by TLDA: BCL2, PGR, SCUBE2, ESR1, MKi67, CCNB1, MYBL2, GRB7, ERBB2, MMP11, CD68, BAG1, MAPT, MS4A1; ACTB, GAPDH, GUSB, NUP214 , VCAN. A single-tube qRT-PCR verification was performed using 289 FFPE samples that met the above sample collection requirements and complete clinical follow-up information.
[0079] (1) RNA extraction of 289 cases of FFPE samples: 4 slices of 20 μm slices or 8 slices of 10 μm slices were taken from each sample, and RNA was extracted according to the instruction of HighPure FFPET RNA Isolation Kit (Roche). The extracted RNA was quantified and qualified by NanoDrop-2000 After the control, the downstream reverse transcription experiment was carried out.
[0080] (2) 289 cases of FFPE sample RNA were reverse-transcribed into cDNA: take 1 μg of total RNA according to VILO TM MasterMix kit (Invitrogen) manu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com